000 | 01273 a2200349 4500 | ||
---|---|---|---|
005 | 20250517201836.0 | ||
264 | 0 | _c20190412 | |
008 | 201904s 0 0 eng d | ||
022 | _a1875-5631 | ||
024 | 7 |
_a10.2174/1566523218666180214092536 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhuang, Quan | |
245 | 0 | 0 |
_aCX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe? _h[electronic resource] |
260 |
_bCurrent gene therapy _c2017 |
||
300 |
_a442-452 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCX3C Chemokine Receptor 1 _xmetabolism |
650 | 0 | 4 |
_aChemokine CX3CL1 _xmetabolism |
650 | 0 | 4 |
_aDiabetic Nephropathies _xmetabolism |
650 | 0 | 4 |
_aGlomerulonephritis, IGA _xmetabolism |
650 | 0 | 4 | _aGraft Rejection |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney Diseases _xetiology |
650 | 0 | 4 |
_aKidney Neoplasms _xmetabolism |
650 | 0 | 4 |
_aLupus Nephritis _xmetabolism |
650 | 0 | 4 |
_aSepsis _xcomplications |
700 | 1 | _aCheng, Ke | |
700 | 1 | _aMing, Yingzi | |
773 | 0 |
_tCurrent gene therapy _gvol. 17 _gno. 6 _gp. 442-452 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/1566523218666180214092536 _zAvailable from publisher's website |
999 |
_c28089038 _d28089038 |